文献速递眼底病与葡萄膜炎

糖尿病合并慢性肾脏病患者的糖尿病视网膜病变患病率及死亡风险

Prevalence of Diabetic Retinopathy and Associated Mortality Among Diabetic Adults With and Without Chronic Kidney Disease.
PubMed 文献 · Am J Ophthalmol · 2018-10-25

研究基于NHANES 2005-2008数据,纳入≥40岁糖尿病成人,估计糖尿病视网膜病变(DR)患病率及死亡风险。合并慢性肾脏病(CKD)者DR患病率为36.2%,威胁视力DR为8.2%;DR合并CKD者全因死亡风险增加3.6倍。

要点

  • 糖尿病合并CKD者DR患病率36.2%,威胁视力DR为8.2%。
  • DR合并CKD者较无DR无CKD者全因死亡风险增加3.6倍。
  • HbA1c每升高1%、糖尿病病程每增5年、收缩压每升10mmHg,DR风险分别增40%、30%、30%。

核心结论

  • 超过三分之一的糖尿病合并CKD患者患有DR,且DR合并CKD者死亡风险更高。
  • 许多与DR相关的危险因素是可改变的。

研究设计与样本

  • 横断面研究,使用2005-2008年美国国家健康与营养调查(NHANES)数据,纳入≥40岁糖尿病成人,随访至2011年12月31日确定生命状态。

主要发现

  • DR总体患病率为27.8%(95% CI 24.3-31.7),合并CKD者为36.2%(95% CI 30.1-42.7),无CKD者为23.4%(95% CI 19.2-28.1)。
  • 威胁视力DR总体患病率为4.2%(95% CI 3.2-5.5),合并CKD者为8.2%(95% CI 5.4-12.2),无CKD者为2.0%(95% CI 1.2-3.5)。
  • 多变量调整模型中,DR与CKD呈正相关但不显著(OR=1.1,95% CI 0.7-1.7)。
  • HbA1c每升高1%,DR风险增加40%(OR=1.4,95% CI 1.1-1.6);糖尿病病程每增加5年,风险增加30%(OR=1.3,95% CI 1.1-1.5);收缩压每升高10 mmHg,风险增加30%(OR=1.3,95% CI 1.1-1.5);胰岛素治疗者风险增加6倍(OR=6.2,95% CI 2.6-14.8)。
  • 与既无DR也无CKD的糖尿病患者相比,DR合并CKD者全因死亡调整风险增加3.6倍(95% CI 1.5-9.1)。

关键数值与推荐

  • 糖尿病定义为HbA1c≥6.5%或自报糖尿病;CKD定义为尿白蛋白/肌酐≥30 mg/g或肾小球滤过率<60 mL/min/1.73 m2。

临床怎么用

  • 对糖尿病合并CKD患者应加强DR筛查,关注威胁视力DR。
  • 管理可改变危险因素如血糖、血压和胰岛素治疗可能降低DR风险。
  • DR合并CKD患者死亡风险更高,需综合管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To estimate prevalence and severity of diabetic retinopathy (DR) among U.S. adults with diabetes and with or without chronic kidney disease (CKD), and assess associated risk of mortality. DESIGN: Cross-sectional study with national survey data. METHODS: The cohort included adults ≥40 years old with diabetes in the National Health and Nutrition Examination Surveys (NHANES) 2005-2008. Vital status was determined through December 31, 2011. We defined diabetes as hemoglobin A1c ≥6.5% or self-report and CKD by urinary albumin/creatinine ≥30 mg/g or glomerular filtration rate <60 mL/min/1.73 m2. The main outcomes were DR and mortality. RESULTS: Prevalence of DR was 27.8% (95% CI 24.3-31.7), 36.2% (95%CI 30.1-42.7), and 23.4% (95% CI 19.2-28.1), overall, with and without CKD. Prevalence of vision-threatening DR was 4.2% (95% CI 3.2-5.5), 8.2% (95% CI 5.4-12.2), and 2.0% (95% CI 1.2-3.5), respectively. In a multivariable adjusted model, DR was positively but nonsignificantly associated with CKD (OR = 1.1, 95% CI 0.7-1.7), was 40% higher per 1% increase in hemoglobin A1c (OR = 1.4, 95% CI 1.1-1.6), was 30% higher per 5 years additional diabetes duration (OR = 1.3, 95% CI 1.1-1.5), was 30% higher per 10 mm Hg increase in systolic blood pressure (OR = 1.3, 95% CI 1.1-1.5), and was 6-fold higher with insulin treatment (OR = 6.2, 95% CI 2.6-14.8). Compared with diabetic participants with neither DR nor CKD, those with DR and CKD had a 3.6-fold (95% CI 1.5-9.1) increased adjusted risk for all-cause mortality. CONCLUSIONS: Over one third of persons with diabetes and CKD had DR. The risk of death was higher with than without CKD and DR. Many of the studied risk factors associated with DR are modifiable.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Pavkov ME, Harding JL, Chou CF, et al. Prevalence of Diabetic Retinopathy and Associated Mortality Among Diabetic Adults With and Without Chronic Kidney Disease. Am J Ophthalmol. 2018. PMID: 30691612. doi:10.1016/j.ajo.2018.10.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。